Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 44Active not recruiting 27Completed 6Not yet recruiting 5Terminated 3Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 10Prostatic Neoplasms 7Lung Neoplasms 6Recurrence 4Multiple Myeloma 4Lymphoma, B-Cell 4Lymphoma 4Colorectal Neoplasms 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Urologic Neoplasms 2Solid Tumor 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Leukemia 2Glioblastoma 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Vasculitis 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Burkitt Lymphoma × 90 days × Clear all
NCT07196111 2026-05-28

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Guangzhou Bio-gene Technology Co., Ltd

Phase EARLY_PHASE1 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡